312 related articles for article (PubMed ID: 17413905)
21. The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery.
Mengistu AM; Röhm KD; Boldt J; Mayer J; Suttner SW; Piper SN
Anesth Analg; 2008 Aug; 107(2):391-7. PubMed ID: 18633013
[TBL] [Abstract][Full Text] [Related]
22. Use of aprotinin in cardiac surgery: effectiveness and safety in a population-based study.
Jakobsen CJ; Søndergaard F; Hjortdal VE; Johnsen SP
Eur J Cardiothorac Surg; 2009 Nov; 36(5):863-8. PubMed ID: 19782573
[TBL] [Abstract][Full Text] [Related]
23. High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery.
Tassani P; Augustin N; Barankay A; Braun SL; Zaccaria F; Richter JA
J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):682-6. PubMed ID: 11139109
[TBL] [Abstract][Full Text] [Related]
24. A randomized, controlled trial of aprotinin in neonates undergoing open-heart surgery.
Williams GD; Ramamoorthy C; Pentcheva K; Boltz MG; Kamra K; Reddy VM
Paediatr Anaesth; 2008 Sep; 18(9):812-9. PubMed ID: 18768040
[TBL] [Abstract][Full Text] [Related]
25. Is aprotinin indicated for reoperative valvular surgery?
Goldstein DJ; DeRosa CM; Seldomridge JA; Weinberg AD; Oz MC; Smith CR
J Heart Valve Dis; 1997 Jan; 6(1):88-92. PubMed ID: 9044087
[TBL] [Abstract][Full Text] [Related]
26. The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass.
Manrique A; Jooste EH; Kuch BA; Lichtenstein SE; Morell V; Munoz R; Ellis D; Davis PJ
Anesth Analg; 2009 Jul; 109(1):45-52. PubMed ID: 19535694
[TBL] [Abstract][Full Text] [Related]
27. [Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery].
Yasim A; Aşik R; Atahan E
Anadolu Kardiyol Derg; 2005 Mar; 5(1):36-40. PubMed ID: 15755701
[TBL] [Abstract][Full Text] [Related]
28. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
[TBL] [Abstract][Full Text] [Related]
29. The management of bleeding following surgery requiring hypothermic circulatory arrest.
Rooney SJ; Bonser RS
J Card Surg; 1997; 12(2 Suppl):238-42. PubMed ID: 9271752
[TBL] [Abstract][Full Text] [Related]
30. Aprotinin improves functional outcome but not cerebral infarct size in an experimental model of stroke during cardiopulmonary bypass.
Homi HM; Sheng H; Arepally GM; Mackensen GB; Grocott HP
Anesth Analg; 2010 Jul; 111(1):38-45. PubMed ID: 20519424
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of aprotinin use for reoperative valvular surgery.
Rodrigues AJ; Evora PR; Bassetto S; Luciano PM; Alves L; Filho AS; Vicente WV
Ann Thorac Surg; 2007 Jun; 83(6):2060-5. PubMed ID: 17532397
[TBL] [Abstract][Full Text] [Related]
32. Aprotinin in primary cardiac surgery: operative outcome of propensity score-matched study.
Ngaage DL; Cale AR; Cowen ME; Griffin S; Guvendik L
Ann Thorac Surg; 2008 Oct; 86(4):1195-202. PubMed ID: 18805159
[TBL] [Abstract][Full Text] [Related]
33. Defining the role of aprotinin in heart transplantation.
Prendergast TW; Furukawa S; Beyer AJ; Eisen HJ; McClurken JB; Jeevanandam V
Ann Thorac Surg; 1996 Sep; 62(3):670-4. PubMed ID: 8783991
[TBL] [Abstract][Full Text] [Related]
34. Increased incidence of acute kidney injury with aprotinin use during cardiac surgery detected with urinary NGAL.
Wagener G; Gubitosa G; Wang S; Borregaard N; Kim M; Lee HT
Am J Nephrol; 2008; 28(4):576-82. PubMed ID: 18264006
[TBL] [Abstract][Full Text] [Related]
35. Cardiopulmonary bypass duration is an independent predictor of morbidity and mortality after cardiac surgery.
Salis S; Mazzanti VV; Merli G; Salvi L; Tedesco CC; Veglia F; Sisillo E
J Cardiothorac Vasc Anesth; 2008 Dec; 22(6):814-22. PubMed ID: 18948034
[TBL] [Abstract][Full Text] [Related]
36. Aprotinin is not associated with postoperative renal impairment after primary coronary surgery.
Lindvall G; Sartipy U; Ivert T; van der Linden J
Ann Thorac Surg; 2008 Jul; 86(1):13-9. PubMed ID: 18573391
[TBL] [Abstract][Full Text] [Related]
37. Effects of aprotinin dosage on renal function: an analysis of 8,548 cardiac surgical patients treated with different dosages of aprotinin.
Dietrich W; Busley R; Boulesteix AL
Anesthesiology; 2008 Feb; 108(2):189-98. PubMed ID: 18212563
[TBL] [Abstract][Full Text] [Related]
38. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.
Breuer T; Martin K; Wilhelm M; Wiesner G; Schreiber C; Hess J; Lange R; Tassani P
Eur J Cardiothorac Surg; 2009 Jan; 35(1):167-71; author reply 171. PubMed ID: 19027313
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of aprotinin as a blood conservation technique for adult deformity spinal surgery: a retrospective study.
Tayyab NA; Mariller MM; Rivlin M; Berekashvili K; Bitan FD; Casden AM; Kuflik P; Neuwirth MG
Spine (Phila Pa 1976); 2008 Jul; 33(16):1775-81. PubMed ID: 18628710
[TBL] [Abstract][Full Text] [Related]
40. Gender-specific association of the factor V Leiden mutation with fertility and fecundity in a historic cohort. The Leiden 85-Plus Study.
van Dunné FM; de Craen AJ; Heijmans BT; Helmerhorst FM; Westendorp RG
Hum Reprod; 2006 Apr; 21(4):967-71. PubMed ID: 16439508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
